Raymond James Financial’s Crescent Capital BDC CCAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.99M Sell
163,795
-94,007
-36% -$1.29M ﹤0.01% 3360
2025
Q4
$3.62M Sell
257,802
-18,104
-7% -$257K ﹤0.01% 2771
2025
Q3
$3.93M Buy
275,906
+39,089
+17% +$585K ﹤0.01% 2634
2025
Q2
$3.34M Buy
236,817
+26,532
+13% +$407K ﹤0.01% 2677
2025
Q1
$3.6M Buy
210,285
+15,155
+8% +$282K ﹤0.01% 2551
2024
Q4
$3.75M Buy
+195,130
New +$3.69M ﹤0.01% 2505

Other funds holding CCAP

Raymond James Financial's CCAP Position: Q1 2026 in Review

Raymond James Financial reduced its Crescent Capital BDC (CCAP) stake by 36% in Q1 2026, selling an estimated $1.29M and leaving 163,795 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #3360.

Raymond James Financial first reported a position in CCAP in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.93M in Q3 2025. 85 funds tracked by Wall St. Rank hold CCAP as of Q1 2026.

  • Raymond James Financial held 163,795 shares of Crescent Capital BDC worth $1.99M as of Q1 2026.
  • Raymond James Financial sold 94,007 Crescent Capital BDC shares in Q1 2026, an estimated $1.29M.
  • Crescent Capital BDC made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #3360 holding.
  • Raymond James Financial first reported a position in Crescent Capital BDC in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Crescent Capital BDC position peaked at $3.93M in Q3 2025.
  • 85 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.